Autor: |
Thomas Vazquez, Mahtab Forouzandeh, Deborah Lin, Felix Chin, Mariana Perez, Alberto Caban-Martinez, Andrea Maderal |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
Archives of Dermatological Research. |
ISSN: |
1432-069X |
DOI: |
10.1007/s00403-022-02457-6 |
Popis: |
Biologics are the most effective treatment for moderate-to-severe psoriasis. Insurance approval and need for prior authorization continue to be a barrier to care for many patients with psoriasis and psoriatic arthritis. We sought to determine whether race/ethnicity, insurance type, and provider specialty affect biologic approval times. Records from the University of Miami Health System were reviewed, and 101 patients were included. Need for a prior authorization was significantly associated with long waits (p = 2.4 × 10 |
Databáze: |
OpenAIRE |
Externí odkaz: |
|